Niobium
- Generic Name
- Niobium
- Drug Type
- Small Molecule
- Chemical Formula
- Nb
- CAS Number
- 7440-03-1
- Unique Ingredient Identifier
- 05175J654G
- Background
Niobium has been used in trials studying the treatment of Obesity and Overweight.
Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Specialist Treatment
Phase 2
Completed
- Conditions
- Binge-Eating DisorderObesity
- Interventions
- Behavioral: Cognitive-Behavioral Therapy (CBT)
- First Posted Date
- 2017-02-24
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- Yale University
- Target Recruit Count
- 31
- Registration Number
- NCT03063606
- Locations
- 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States
Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy
Phase 2
Completed
- Conditions
- Binge-Eating DisorderObesity
- Interventions
- Other: Placebo
- First Posted Date
- 2017-02-08
- Last Posted Date
- 2024-02-02
- Lead Sponsor
- Yale University
- Target Recruit Count
- 68
- Registration Number
- NCT03047005
- Locations
- 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States
Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment
Phase 2
Completed
- Conditions
- Binge-eating DisorderObesity
- Interventions
- Behavioral: Behavioral Weight Loss (BWL) counselingOther: Placebo
- First Posted Date
- 2017-02-07
- Last Posted Date
- 2023-03-08
- Lead Sponsor
- Yale University
- Target Recruit Count
- 136
- Registration Number
- NCT03045341
- Locations
- 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States
Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects
Phase 3
Completed
- Conditions
- ObesityOverweight
- Interventions
- First Posted Date
- 2013-01-09
- Last Posted Date
- 2015-12-29
- Lead Sponsor
- Orexigen Therapeutics, Inc
- Target Recruit Count
- 242
- Registration Number
- NCT01764386
- Locations
- 🇺🇸
Radiant Research-Akron, Akron, Ohio, United States
🇺🇸PMG Research of Winston-Salem, Hickory, North Carolina, United States
🇺🇸PMG Research of Salisbury, Salisbury, North Carolina, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath